Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention von Ho, Tony W, Connor, Kathryn M, Zhang, Ying, Pearlman, Eric, Koppenhaver, Janelle, Fan, Xiaoyin, Lines, Christopher, Edvinsson, Lars, Goadsby, Peter J, Michelson, David

Volltext

Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes von Hodgson, Darren R., Dougherty, Brian A., Lai, Zhongwu, Fielding, Anitra, Grinsted, Lynda, Spencer, Stuart, O’Connor, Mark J., Ho, Tony W., Robertson, Jane D., Lanchbury, Jerry S., Timms, Kirsten M., Gutin, Alexander, Orr, Maria, Jones, Helen, Gilks, Blake, Womack, Chris, Gourley, Charlie, Ledermann, Jonathan, Barrett, J. Carl

Volltext

Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular Characterization von Lheureux, Stephanie, Lai, Zhongwu, Dougherty, Brian A, Runswick, Sarah, Hodgson, Darren R, Timms, Kirsten M, Lanchbury, Jerry S, Kaye, Stan, Gourley, Charlie, Bowtell, David, Kohn, Elise C, Scott, Claire, Matulonis, Ursula, Panzarella, Tony, Karakasis, Katherine, Burnier, Julia V, Gilks, C Blake, O'Connor, Mark J, Robertson, Jane D, Ledermann, Jonathan, Barrett, J Carl, Ho, Tony W, Oza, Amit M

Volltext

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised,... von Ho, Tony W, Dr, Ferrari, Michel D, Prof, Dodick, David W, Prof, Galet, Vince, PhD, Kost, James, PhD, Fan, Xiaoyin, PhD, Leibensperger, Heather, BS, Froman, Samar, BS, Assaid, Christopher, PhD, Lines, Christopher, PhD, Koppen, Hille, MD, Winner, Paul K, DO

Volltext

Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine von Hewitt, David J, Aurora, Sheena K, Dodick, David W, Goadsby, Peter J, Ge, Yang (Joy), Bachman, Robert, Taraborelli, Donna, Fan, Xiaoyin, Assaid, Christopher, Lines, Christopher, Ho, Tony W

Volltext

High frequency CCR5 editing in human hematopoietic stem progenitor cells protects xenograft mice from HIV infection von Claiborne, Daniel T., Detwiler, Zachary, Docken, Steffen S., Borland, Todd D., Cromer, Deborah, Simkhovich, Amanda, Ophinni, Youdiil, Okawa, Ken, Bateson, Timothy, Chen, Tao, Hudson, Wesley, Trifonova, Radiana, Davenport, Miles P., Ho, Tony W., Boutwell, Christian L., Allen, Todd M.

Volltext

Biological and clinical evidence for somatic mutations in BRCA1 and BRCA2 as predictive markers for olaparib response in high-grade serous ovarian cancers in the maintenance settin... von Dougherty, Brian A, Lai, Zhongwu, Hodgson, Darren R, Orr, Maria C M, Hawryluk, Matthew, Sun, James, Yelensky, Roman, Spencer, Stuart K, Robertson, Jane D, Ho, Tony W, Fielding, Anitra, Ledermann, Jonathan A, Barrett, J Carl

Volltext

Outcomes and endpoints in cancer trials: bridging the divide von Wilson, Michelle K, FRACP, Collyar, Deborah, BSc, Chingos, Diana T, MFA, Friedlander, Michael, Prof, Ho, Tony W, MD, Karakasis, Katherine, MSc, Kaye, Stan, Prof, Parmar, Mahesh K B, Prof, Sydes, Matthew R, CStat, Tannock, Ian F, Prof, Oza, Amit M, Prof

Volltext

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. Reply von Frangoul, Haydar, Ho, Tony W, Corbacioglu, Selim

Volltext

Long-Term Tolerability of Telcagepant for Acute Treatment of Migraine in a Randomized Trial von Connor, Kathryn M., Aurora, Sheena K., Loeys, Tom, Ashina, Messoud, Jones, Christopher, Giezek, Hilde, Massaad, Rachid, Williams-Diaz, Angela, Lines, Christopher, Ho, Tony W.

Volltext

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia von Frangoul, Haydar, Altshuler, David, Cappellini, M. Domenica, Chen, Yi-Shan, Domm, Jennifer, Eustace, Brenda K, Foell, Juergen, de la Fuente, Josu, Grupp, Stephan, Handgretinger, Rupert, Ho, Tony W, Kattamis, Antonis, Kernytsky, Andrew, Lekstrom-Himes, Julie, Li, Amanda M, Locatelli, Franco, Mapara, Markus Y, de Montalembert, Mariane, Rondelli, Damiano, Sharma, Akshay, Sheth, Sujit, Soni, Sandeep, Steinberg, Martin H, Wall, Donna, Yen, Angela, Corbacioglu, Selim

Volltext

Safety and Clinical Activity of the Programmed Death-Ligand 1 Inhibitor Durvalumab in Combination With Poly (ADP-Ribose) Polymerase Inhibitor Olaparib or Vascular Endothelial Growt... von Lee, Jung-Min, Cimino-Mathews, Ashley, Peer, Cody J, Zimmer, Alexandra, Lipkowitz, Stanley, Annunziata, Christina M, Cao, Liang, Harrell, Maria I, Swisher, Elizabeth M, Houston, Nicole, Botesteanu, Dana-Adriana, Taube, Janis M, Thompson, Elizabeth, Ogurtsova, Aleksandra, Xu, Haiying, Nguyen, Jeffers, Ho, Tony W, Figg, William D, Kohn, Elise C

Volltext

Neurokinin B Receptor Antagonism in Women With Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Trial von George, Jyothis T, Kakkar, Rahul, Marshall, Jayne, Scott, Martin L, Finkelman, Richard D, Ho, Tony W, Veldhuis, Johannes, Skorupskaite, Karolina, Anderson, Richard A, McIntosh, Stuart, Webber, Lorraine

Volltext

Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease: Two Randomized Clinical Trials and Lessons Learned von Hauser, Robert A, Stocchi, Fabrizio, Rascol, Olivier, Huyck, Susan B, Capece, Rachel, Ho, Tony W, Sklar, Peter, Lines, Christopher, Michelson, David, Hewitt, David

Volltext

Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease von Stocchi, Fabrizio, Rascol, Olivier, Hauser, Robert A, Huyck, Susan, Tzontcheva, Anjela, Capece, Rachel, Ho, Tony W, Sklar, Peter, Lines, Christopher, Michelson, David, Hewitt, David J

Volltext

CGRP Receptor Antagonism and Migraine von Edvinsson, Lars, Ho, Tony W.

Volltext

Intermediate clinical endpoints: A bridge between progression‐free survival and overall survival in ovarian cancer trials von Matulonis, Ursula A., Oza, Amit M., Ho, Tony W., Ledermann, Jonathan A.

Volltext

Randomized, controlled trial of telcagepant for the acute treatment of migraine von CONNOR, K. M, SHAPIRO, R. E, DIENER, H.-C, LUCAS, S, KOST, J, FAN, X, FEI, K, ASSAID, C, LINES, C, HO, T. W

Volltext

Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine von Ho, Tony W, Ho, Andrew P, Ge, Yang (Joy), Assaid, Christopher, Gottwald, Regina, MacGregor, E Anne, Mannix, Lisa K, van Oosterhout, Willebrordus PJ, Koppenhaver, Janelle, Lines, Christopher, Ferrari, Michel D, Michelson, David

Volltext

Inhibition of capsaicin‐induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK‐0974) von Sinclair, Simon R., Kane, Stefanie A., Van der Schueren, Bart J., Xiao, Alan, Willson, Kenneth J., Boyle, Janet, De Lepeleire, Inge, Xu, Yang, Hickey, Lisa, Denney, William S., Li, Chi‐Chung, Palcza, John, Vanmolkot, Floris H. M., Depré, Marleen, Van Hecken, Anne, Murphy, M. Gail, Ho, Tony W., De Hoon, Jay N.

Volltext